Persistent URL of this record https://hdl.handle.net/1887/49549
Documents
-
- Download
- Title Pages_Contents
- open access
-
- Download
- Chapter 2
- open access
- Full text at publishers site
-
- Download
- Chapter 5
- open access
- Full text at publishers site
-
- Download
- Chapter 6
- open access
- Full text at publishers site
-
- Download
- Chapter 7: Summary in English
- open access
-
- Download
- Chapter 8: Summary in Dutch
- open access
-
- Download
- Propositions
- open access
In Collections
This item can be found in the following collections:
Immune-based therapies in ovarian cancer
might lie in a combination of chemotherapy and immunotherapy. This thesis focuses on the interaction of chemotherapy with the immune system and describes new combined chemo-immunotherapy treatment strategies. This thesis has explored new strategies, immune-modulation of the IL-6 pathway and a vaccine against p53, to enhance immune surveillance and to disable tumour immune evasion in ovarian cancer patients. The future challenge for immunotherapy against ovarian cancer is a tailored combinatorial approach to test the rationale of potentially synergistic
therapies that can induce efficient antitumour immunity and prolong patients’ survival.
- All authors
- Dijkgraaf, E.M.
- Supervisor
- Burg, S.H. van der; Hoeven, J.J.M. van der
- Co-supervisor
- Kroep, J.R.; Schoenmaekers-Welters, M.J.P.
- Committee
- Ossendorp, F.A.; Morreau, J.; Ottevanger, P.B.
- Qualification
- Doctor (dr.)
- Awarding Institution
- Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University
- Date
- 2017-06-13
- ISBN (print)
- 9789462995734